/Companies

Valotx

Helsinki, FI · Founded 2016 · 11 employees on LinkedIn · 1 known investors

Find your way into Valotx

Sign up to see every warm intro you have to Valotx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Valotx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.

Investors · 1

Related companies · 4

Companies working in the same space as Valotx.

Frequently asked questions

What does Valotx do?
ValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.
Who are Valotx's investors?
Valotx's investors include CDP Venture Capital.
Where is Valotx headquartered?
Valotx is headquartered in Helsinki, FI.